152 related articles for article (PubMed ID: 1374906)
21. Type II collagen pro-alpha-chains containing a Gly574Ser mutation are not incorporated into the cartilage matrix of transgenic mice.
Maddox BK; Garofalo S; Keene DR; Smith C; Horton WA
Matrix Biol; 1997 Aug; 16(3):93-103. PubMed ID: 9314159
[TBL] [Abstract][Full Text] [Related]
22. An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1). Young mice have a variable phenotype of a chondrodysplasia and older mice have osteoarthritic changes in joints.
Helminen HJ; Kiraly K; Pelttari A; Tammi MI; Vandenberg P; Pereira R; Dhulipala R; Khillan JS; Ala-Kokko L; Hume EL
J Clin Invest; 1993 Aug; 92(2):582-95. PubMed ID: 8349798
[TBL] [Abstract][Full Text] [Related]
23. Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice.
Garofalo S; Metsäranta M; Ellard J; Smith C; Horton W; Vuorio E; de Crombrugghe B
Proc Natl Acad Sci U S A; 1993 May; 90(9):3825-9. PubMed ID: 8483900
[TBL] [Abstract][Full Text] [Related]
24. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
[TBL] [Abstract][Full Text] [Related]
25. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia.
Zabel B; Hilbert K; Stöss H; Superti-Furga A; Spranger J; Winterpacht A
Am J Med Genet; 1996 May; 63(1):123-8. PubMed ID: 8723097
[TBL] [Abstract][Full Text] [Related]
26. Type II collagen defect in two sibs with the Goldblatt syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity.
Bonaventure J; Stanescu R; Stanescu V; Allain JC; Muriel MP; Ginisty D; Maroteaux P
Am J Med Genet; 1992 Dec; 44(6):738-53. PubMed ID: 1481841
[TBL] [Abstract][Full Text] [Related]
27. Effect of relaxin on the phenotype of collagens synthesized by cultured rabbit chondrocytes.
Bonaventure J; de La Tour B; Tsagris L; Eddie LW; Tregear G; Corvol MT
Biochim Biophys Acta; 1988 Nov; 972(2):209-20. PubMed ID: 2461230
[TBL] [Abstract][Full Text] [Related]
28. Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect.
Winterpacht A; Hilbert M; Schwarze U; Mundlos S; Spranger J; Zabel BU
Nat Genet; 1993 Apr; 3(4):323-6. PubMed ID: 7981752
[TBL] [Abstract][Full Text] [Related]
29. Amplification of cDNAs for human cartilage-specific types II, IX and XI collagens from chondrocytes and Epstein-Barr virus-transformed lymphocytes.
Dharmavaram RM; Baldwin CT; Reginato AM; Jimenez SA
Matrix; 1993 Mar; 13(2):125-33. PubMed ID: 8388073
[TBL] [Abstract][Full Text] [Related]
30. Stable transfection of human fetal chondrocytes with a type II procollagen minigene: expression of the mutant protein and alterations in the structure of the extracellular matrix in vitro.
Dharmavaram RM; Liu G; Tuan RS; Stokes DG; Jiménez SA
Arthritis Rheum; 1999 Jul; 42(7):1433-42. PubMed ID: 10403271
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and molecular characterization of stromelysin synthesized by human osteoarthritic chondrocytes stimulated with recombinant human interleukin-1.
Ganu VS; Hu SI; Melton R; Winter C; Goldberg VM; Haqqi TM; Malemud CJ
Clin Exp Rheumatol; 1994; 12(5):489-96. PubMed ID: 7531123
[TBL] [Abstract][Full Text] [Related]
32. Type II collagenopathies: are there additional family members?
Freisinger P; Bonaventure J; Stoess H; Pontz BF; Emmrich P; Nerlich A
Am J Med Genet; 1996 May; 63(1):137-43. PubMed ID: 8723099
[TBL] [Abstract][Full Text] [Related]
33. Approaches to investigating growth plate cartilage in the human chondrodysplasias.
Horton WA
Pathol Immunopathol Res; 1988; 7(1-2):85-9. PubMed ID: 3065769
[No Abstract] [Full Text] [Related]
34. Recurrent substitutions of arginine 789 by cysteine in pro-alpha 1 (II) collagen chains produce spondyloepiphyseal dysplasia congenita.
Chan D; Rogers JF; Bateman JF; Cole WG
J Rheumatol Suppl; 1995 Feb; 43():37-8. PubMed ID: 7752132
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a biomaterial with cartilage-like properties expressing type X collagen generated in vitro using neonatal porcine articular and growth plate chondrocytes.
Estrada LE; Dodge GR; Richardson DW; Farole A; Jimenez SA
Osteoarthritis Cartilage; 2001 Feb; 9(2):169-77. PubMed ID: 11237664
[TBL] [Abstract][Full Text] [Related]
36. Type X collagen biosynthesis and expression in avian tibial dyschondroplasia.
Reginato AM; Bashey RI; Rosselot G; Leach RM; Gay CV; Jimenez SA
Osteoarthritis Cartilage; 1998 Mar; 6(2):125-36. PubMed ID: 9692067
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor binding to an AP-1 site is associated with the activation of pro-alpha 1(I)-collagen gene in dedifferentiating chondrocytes.
Määttä A; Glumoff V; Paakkonen P; Liska D; Penttinen RP; Elima K
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):365-71. PubMed ID: 8373351
[TBL] [Abstract][Full Text] [Related]
38. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis.
So CL; Kaluarachchi K; Tam PP; Cheah KS
Osteoarthritis Cartilage; 2001; 9 Suppl A():S160-73. PubMed ID: 11680681
[TBL] [Abstract][Full Text] [Related]
39. Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels.
Goldring MB; Sohbat E; Elwell JM; Chang JY
Eur J Rheumatol Inflamm; 1990; 10(1):10-21. PubMed ID: 2146129
[TBL] [Abstract][Full Text] [Related]
40. Expression of the human chondrocyte phenotype in vitro.
Aulthouse AL; Beck M; Griffey E; Sanford J; Arden K; Machado MA; Horton WA
In Vitro Cell Dev Biol; 1989 Jul; 25(7):659-68. PubMed ID: 2666386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
